{
  "id": "549d76a0-a454-4740-87a8-0667da707e25",
  "patient_id": "bc8a3bb5-01b7-4bbd-a79a-43f812620f3a",
  "encounter_id": "5f9f4650-7af0-451a-813d-6693489bdc44",
  "analysis_type": "Genetic Testing Recommendation",
  "input_text": "Patient: Steven Ortega, DOB: 2006-02-16, Gender: Male\n\nChief Complaint: headache\n\nS: Patient Describes no history of illness\n\nO: No physical exam documented.\n\nA: No assessment documented.\n\nP: No plan documented.\n\n--- IMAGING & SCANS ---\n- ECG (3/25/2025): ECG Scan for Patient\n\n--- IMAGING & SCANS ANALYSIS ---\n\n[Scan 1: ECG (2025-03-25T09:09:28.833517)]\nFile: norm.png\nDescription: ECG Scan for Patient\nAnalysis: Okay, let's analyze this ECG tracing in detail. Here\u2019s a breakdown of what I observe, focusing on both normal findings and potential areas of concern:\n\n**Overall Impression:**\n\nThe ECG shows a sinus rhythm with a heart rate of approximately 75 beats per minute. The rhythm appears regular. However, there are some notable findings that warrant further investigation.\n\n**Detailed Analysis \u2013 Waveform by Waveform:**\n\n* **I, II, III Leads:** These leads show a normal P wave followed by a QRS complex. The QRS complexes are relatively narrow, suggesting a normal ventricular depolarization. The ST segments appear largely isoelectric (flat), which is a good sign.\n* **aVR, aVL Leads:**  Similar to the I, II, III leads, these show normal P waves and QRS complexes.  aVL shows a slight negative deflection during the QRS complex, which is expected.\n* **V1-V6 Leads:**  This is where we see the most significant findings:\n    * **T Wave Abnormalities:** The T waves in V3, V4, V5, and V6 are significantly *inverted* \u2013 they are negative in morphology. This is a key observation. Inverted T waves can be indicative of myocardial ischemia (lack of blood flow to the heart muscle) or infarction (past heart attack).\n    * **ST Segment Depression:** There is subtle ST-segment depression (flattening) in V3, V4, V5, and V6. This further supports the possibility of ischemia.\n    * **QRS Complexes:** The QRS complexes appear relatively narrow in V1-V6, but a slight widening is possible in V5 and V6, which could be related to the inverted T waves.\n* **Rhythm:** The rhythm is regular. The P waves are present and appear consistent. The PR interval appears to be within the normal range.\n\n**Measurements:**\n\n* **Rate:** Approximately 75 bpm (as estimated from the R-R intervals).\n* **Axis:** The QRS axis appears to be slightly rightward, which could be a normal variation or could be influenced by the inverted T waves.\n* **Intervals:** The PR interval appears normal. The QT interval is not easily measurable due to the ECG's resolution, but it seems within the expected range.\n\n**Possible Abnormalities and Considerations:**\n\n1. **Inverted T Waves:** The most prominent finding is the inverted\n\n\n--- MEDICAL ENTITY ANALYSIS ---\n\nDETAILED_DESCRIPTION: 02-16, -R, verted T\nSIGN_SYMPTOM: headache, depolarization, Abnormal, T waves, flow, Depression, ST-segment depression, flattening, widening\nHISTORY: illness\nDATE: 03, 25\nDIAGNOSTIC_PROCEDURE: ECG, rhythm, heart rate, form by, form, I, II, III Leads, leads, P wave, QRS complex, QRS complexes, ventricular, ST segments, aVR, aVL Leads, I, II, III leads, P waves, aVL, V1-V6 Leads, T Wave, T waves, ST Segment, QRS Complexes, Rhythm, PR interval, Rate, Axis, QRS axis, Intervals, QT interval, Waves\nLAB_VALUE: sinus, 75 beats per minute, regular, normal, narrow, isoelectric, flat, slight negative deflection, *inverted*, negative, within, 75 bpm, slightly rightward\nBIOLOGICAL_STRUCTURE: V3, V4, V5, V6, myocardial, heart muscle, V1-V6, V5 and V6\nDISEASE_DISORDER: ischemia, infarction, heart attack\nSEVERITY: subtle",
  "recommendation": "Unknown",
  "reasoning": "The ECG shows significant abnormalities, specifically inverted T waves and ST-segment depression in leads V3-V6.  These findings are highly suggestive of myocardial ischemia or even a past myocardial infarction, particularly given the patient's age. While the patient's chief complaint is only a headache, the ECG results warrant immediate and thorough investigation.  The literature mentions several conditions that can present with similar ECG findings, including Brugada syndrome, hypertrophic cardiomyopathy, and even Fabry disease.  Brugada syndrome, in particular, is highlighted in the provided literature as a condition that can present with inverted T waves and a risk of sudden cardiac death, although it typically manifests later in life.  However, given the severity of the ECG abnormalities, further investigation is crucial to rule out serious underlying cardiac conditions. Genetic testing would be beneficial to identify potential underlying genetic causes for these findings, allowing for appropriate management and risk assessment.  The absence of a detailed medical history and physical exam makes it difficult to pinpoint a specific diagnosis with high confidence, but the ECG abnormalities alone strongly suggest the need for genetic testing.",
  "confidence": "70%",
  "model_used": "Gemini-Pro",
  "retrieved_docs": [
    {
      "id": "barth_txt_9",
      "contents": " Spencer et al [2006] observed that with standard cardiac medications for dilated cardiomyopathy more than 16/30 afected males had normal ejection fraction and lef ventricular diastolic volume. However, some responded to therapy initially but deteriorated afer a period of stability, requiring cardiac transplantation [Adwani et al 1997, Mangat et al 2007]. \nArrhythmia. Te risk for arrhythmia (including supraventricular and ventricular tachycardia) and sudden death is increased. While arrhythmia has been most ofen reported in adolescents and young adults, it can occur in children of all ages. EKG abnormalities can include repolarization abnormalities and prolonged QTc intervals. \nAll 20 afected males with EKGs in the French cohort had a normal sinus rhythm. Repolarization abnormalities (including ST fattening and T-wave inversion) were seen in 17. Five had QTc values within the normal range (QTc ${<}420\\;\\mathrm{ms}_{}$ ), and fve had QTc greater than $460\\:\\mathrm{ms}$ . Te median QTc was $440\\:\\mathrm{ms}$ (range: $360{-}530~\\mathrm{ms})$ ). In the study by Kang et al [2016], nine of 21 afected individuals had prolonged QTc of greater than $460~\\mathrm{ms}$ and three had borderline QTc prolongation between 450 and $460~\\mathrm{ms}$ . \nIn fve instances of ventricular arrhythmia leading to cardiac arrest or placement of an internal defbrillato r [Spencer et al 2005]: \n\u2022 All fve individuals had normal QTc intervals;   \n\u2022 All fve had a history of recurrent vasovagal symptoms including postural dizziness, nausea, and pallor suggestive of autonomic instability;   \n\u2022 Four had only mild LV dilatation and low normal to mildly depressed LV function; only one had poor but stable LV function prior to cardiac arrest;   \n\u2022 Tree showed inducible ventricular arrhythmias on electrophysiologic testing;   \n",
      "token_count": 479,
      "sentence_count": 15
    },
    {
      "id": "brugada_txt_11",
      "contents": "Note: Data on genetic modifers (e.g., susceptibility loci / polymorphisms identifed through genome-wide association studies) in Brugada syndrome-related genes that may contribute in small ways to risk of a given phenotype are not included in Table 2. \nDifferential Diagnosis \nBrugada syndrome should always be considered in the diferential diagnosis of the following: \n\u2022 Sudden cardiac death and syncope in persons with a structurally normal heart   \n\u2022 SIDS. Brugada syndrome does not usually cause problems at such a young age; however, SCN5A pathogenic variants have been described in a few infants with SIDS. SIDS is believed to be etiologically and genetically heterogeneous [Weese-Mayer et al 2007] with an unknown proportion attributed to Brugada syndrome.   \n\u2022 Sick sinus syndrome. Brugada syndrome could be observed in persons with sick sinus syndrome given the defects observed in cardiac conduction [Nakazato et al 2004]. \nOther conditions that can be associated with ST segment elevation in right precordial leads include the following (adapted from de Oliveira Neto et al [2019] and Wilde et al [2002] with permission). \nAbnormalities that can lead to ST segment elevation in the right precordial leads \n\u2022 Right or lef bundle branch block, lef ventricular hypertrophy   \nAcute myocardial ischemia or infarction   \nAcute myocarditis Hypothermia, causing Osborn wave in EKGs and sometimes resembling Brugada syndrome Right ventricular ischemia or infarction Dissecting aortic aneurysm Acute pulmonary thromboemboli Various central and autonomic nervous system abnormalities Heterocyclic antidepressant overdose Duchenne muscular dystrophy Friedreich ataxia Tiamine defciency   \n\u2022 Hypercalcemia   \nHyperkalemia   \n\u2022 Cocaine intoxication \nMediastinal tumor compressing the right ventricular outfow tract Arrhythmogenic right ventricular cardiomyopathy \nOther conditions that can lead to ST segment elevation in the right precordial leads \nEarly repolarization syndrome Other normal variants (particularly in males) \nMost of the above conditions can give rise to a type 1 EKG, whereas ARVC and Brugada syndrome can both give rise to type 2 and type 3 EKGs.",
      "token_count": 490,
      "sentence_count": 21
    },
    {
      "id": "cadasil_txt_7",
      "contents": " Acute encephalopathy has been described in some individuals, with confusion, headache, pyrexia, seizures, and coma, sometimes leading to death [Adib-Samii et al 2010, Ragno et al 2013, Tan & Markus 2016]. Migraine with aura (especially confusional aura) is associated with increased risk of acute encephalopathy, suggesting that they may share pathophysiologic mechanisms [Tan & Markus 2016]. \nEpilepsy. Epilepsy occurs in $10\\%$ of individuals with CADASIL and presents in middle age, usually secondary to stroke [Haan et al 2007]. In a pooled analysis of previous published cases, three of 105 individuals with CADASIL had a seizure as the initial presenting symptom [Desmond et al 1999]. \nPregnancy. It has been suggested that the risk for migraine with aura is increased during pregnancy, but especially during puerperium (the period between childbirth and the return of the uterus to its normal size) [Roine et al 2005]. Another study found no association between pregnancy and risk for neurologic events or problems during pregnancy [Donnini et al 2017]. See Pregnancy Management. \nOther fndings \n\u2022 Cardiac. Controversy exists as to whether CADASIL is associated with cardiac involvement. In a study from Te Netherlands, nearly $25\\%$ of individuals with CADASIL had a history of acute myocardial infarction (MI) and/or current pathologic Q-waves on electrocardiogram (EKG) [Lesnik Oberstein et al 2003]. Tis percentage was signifcantly higher than in controls without a heterozygous NOTCH3 pathogenic variant. However, another study of 23 individuals with CADASIL found no signs of previous MI on EKG [Cumurciuc et al 2006b]. Two studies have suggested an increased risk for arrhythmias, based on increased QT variability on EKG recording [Rufa et al 2007, Piccirillo et al 2008].   \n\u2022 Nerve. Nerve biopsies may demonstrate signs of axonal damage, demyelination, and ultrastructural changes of the endoneurial blood vessels [Schr\u00f6der et al 2005, Sicurelli et al 2005, Lackovic et al 2012].",
      "token_count": 485,
      "sentence_count": 14
    },
    {
      "id": "thompson_thompson_genetics_8th_edition_medicoscompanion_com_txt_754",
      "contents": " C-25) in the absence of predisposing cardiac conditions (e.g., aortic stenosis) or cardiovascular conditions (e.g., longstanding hypertension). The clinical manifestations of HCM range from asymptomatic to progressive heart failure to sudden cardiac death and vary from individual to individual even within the same family. Common symptoms include shortness of breath (particularly with exertion), chest pain, palpitations, orthostasis, presyncope, and syncope. Most often the LVH of HCM becomes apparent during adolescence or young adulthood, although it may also develop late in life, in infancy, or in childhood. \n\nManagement \nBefore identification of the genes responsible for HCM, diagnosis of HCM could only be made through integration of examination, electrocardiogram, echocardiogram, and invasive angiographic/hemodynamic studies, disproportionately identifying patients with left ventricular outflow obstruction. Genetic testing for HCM is now available and can provide important insights into family management by definitively identifying at-risk relatives (i.e., those who have inherited the family\u2019s pathogenic mutation). Mutations found are considered pathogenic based on the following criteria: (1) cosegregation with the HCM phenotype in family members; (2) previously reported or identified as a cause of HCM; (3) absent from unrelated and ethnic-matched normal controls; (4) important alteration in protein structure and function; and (5) amino acid sequence change in a region of the protein otherwise highly conserved through evolution. However, even with the use of these criteria, a considerable number of variants are classified as VUSs (see Chapter 16), making the test results ambiguous. \nBecause diagnosis and sudden cardiac death risk are both linked to the presence of LVH and because the penetrance of LVH is age-dependent, clinical evaluation must continue longitudinally. Screening is annual during adolescence and early adulthood when LVH most commonly emerges. Early childhood screening is appropriate if there is a family history of early-onset disease or other concerns. During adulthood, screening is recommended approximately every $5$ years or in response to clinical changes because LVH can develop late in life.",
      "token_count": 473,
      "sentence_count": 15
    },
    {
      "id": "fabry_txt_15",
      "contents": "Te clinical manifestations in heterozygous females range from asymptomatic throughout a normal life span to as severe as afected males. Variation in clinical manifestations is attributed to random X-chromosome inactivation [Deegan et al 2006]. More severely afected females are more likely to express the X chromosome with the GLA pathogenic variant in afected organs [Echevarria et al 2016]. \nMost heterozygous females from families in which afected males have the classic phenotype have a milder clinical course and better prognosis than afected males. \nMild manifestations include the characteristic cornea verticillata $(70\\%-90\\%)$ and lenticular opacities that do not impair vision; acroparesthesia $(50\\%-90\\%)$ ; angiokeratomas $(10\\%-50\\%)$ ) that are usually isolated or sparse; hypohidrosis; and chronic abdominal pain. \nWith advancing age, heterozygotes may develop mild-to-moderate LVH and valvular disease. More serious manifestations include signifcant LVH, cardiomegaly, myocardial ischemia, infarction, and cardiac arrhythmias [Deegan et al 2006, Wilcox et al 2008, Lenders et al 2016a]. \nTe occurrence of cerebrovascular disease including transient ischemic attacks and cerebrovascular accidents is consistent with the microvascular pathology of the disease [MacDermot et al 2001]. \nRenal fndings in heterozygotes include isosthenuria; the presence of erythrocytes, leukocytes, and granular and hyaline casts in the urinary sediment; and proteinuria. According to the United States and European dialysis and transplantation registries, approximately $10\\%$ of heterozygotes develop kidney failure requiring dialysis or transplantation. \n\nExcessive guilt, fatigue, occupational difculty, suicidal ideation, and depression have been noted in heterozygotes [Sadek et al 2004]. \nLate-Onset Variants of Fabry Disease \nCardiac manifestations.",
      "token_count": 471,
      "sentence_count": 13
    },
    {
      "id": "rws_txt_7",
      "contents": "stablishing a specifc genetic cause of long QT syndrome (LQ \u2022 Can aid in discussions of prognosis (which are beyond the scope of this GeneReview) and genetic counseling; \u2022 Usually involves a medical history, physical examination, family history, and genomic/genetic testing. \n\nClinical history. Clinical history in individuals with syncope or a cardiac arrest can reveal specifc triggers for the cardiac event that can be gene specifc. On rare occasions LQTS is accompanied by gene-spe cifc extracardiac features. \nPhysical examination. Te great majority of individuals with LQTS do not have associated physical features. On rare occasions, LQTS is accompanied by gene-specifc extracardiac features. Individuals with EKG characteristics suggestive of a specifc LQTS-associated syndrome (e.g., EKG with T-U patterns characteristic of Andersen-Tawil syndrome) can be assessed for physical features of that syndrome. \nFamily history. A three-generation family history should be taken, with attention to relatives with manifestations of LQTS \u2013 including syncope, aborted cardiac arrest, or sudden death in a child or (young) adult \u2013 and documentation of relevant fndings through direct examination or review of medical records, including results of molecular genetic testing and EKG recordings. Specifc focus should also be on triggers of events in relatives, as well as epilepsy (LQTS-associated syncopes may have been attributed to epilepsy). In such instances, review of medical records should include EEG recordings, accompanied by an EKG, which can show QTc prolongation in afected family members. \nEKG evaluation. Te corrected QT (QTc) values on resting EKG and ST-T wave morphology can suggest a specifc genetic cause of LQTS (see Table 2). Additional tests can be helpful to unmask QTc prolongation in individuals with borderline QTc values on resting EKG [Priori et al 2013]: \n\u2022 Exercise EKG, which commonly shows failure of the QTc to shorten normally and even prolongation of the QTc interval [Jervell & Lange-Nielsen 1957, Vincent et al 1991, Swan et al 1998, Horner et al 2011, Sy et al 2011].",
      "token_count": 484,
      "sentence_count": 17
    },
    {
      "id": "propionic-a_txt_10",
      "contents": "Te age of PA diagnosis, frequency of metabolic decompensation, and residual enzymatic activity do not correlate with presence/absence of cardiomyopathy in individuals with PA [Romano et al 2010].   \n\u2022 Rarely, cardiomyopathy can occur as an apparently isolated clinical phenomenon in previously healthy individuals without documented episodes of metabolic decompensation or neurocognitive defcits [Lee et al 2009, Laemmle et al 2014].   \n\u2022 Cardiomyopathy can progress to cardiac failure and may be associated with sudden death [Dionisi-Vici et al 2006]. \nCardiac rhythm abnormalities. A prolonged QT interval is ofen detected in individuals with PA [K\u00f6lker et al 2015b]. Tis can be associated with syncope, arrhythmia, and cardiac arrest [Baumgartner et al 2007, Jameson & Walter 2008, Pena & Burton 2012]. \nGastrointestinal manifestations \n\u2022 Pancreatitis (reported in $3\\%{-}18\\%$ of individuals) may be recurrent and may present with anorexia, recurrent nausea, and abdominal pain [Dionisi-Vici et al 2006, Gr\u00fcnert et al 2012, Pena & Burton 2012]. In some individuals recurrent pancreatitis can lead to insulin-dependent diabetes.   \n\u2022 Poor feeding and lack of appetite are common, afecting up to $76\\%$ of afected individuals [Touati et al 2006].   \n\u2022 Emesis and diarrhea are commonly reported in individuals with PA, becoming a recurrent problem in approximately $6\\%$ [K\u00f6lker et al 2015b].   \n\u2022 Liver issues include hepatomegaly, hypoalbuminemia, and abnormal liver function tests (ALT, AST, GGT, INR, and bilirubin) [Karimzadeh et al 2014, K\u00f6lker et al 2015b]. Te etiology of hepatic dysfunction has not been determined with certainty but may include the inherent metabolic derangement as well as cardiac dysfunction in individuals with cardiomyopathy. \nRenal abnormalities have been infrequently documented and are likely underreported.",
      "token_count": 459,
      "sentence_count": 14
    },
    {
      "id": "thompson_thompson_genetics_8th_edition_medicoscompanion_com_txt_753",
      "contents": " The cardiologist explained to the patient the possibility of hypertrophic cardiomyopathy running in his family. Cardiac examination showed double apical impulse and laterally displaced, split second heart sound, fourth heart sound present, jugular venous pulse, and double carotid arterial pulse. Echocardiogram showed asymmetrical septal hypertrophy with no structural anomalies, diagnostic of hypertrophic cardiomyopathy. Consistent with his clinical history, physical features, and family history, DNA testing identified an Arg403Gln mutation in MYH7. \nBACKGROUND \nDisease Etiology and Incidence \nHypertrophic cardiomyopathy (HCM, MIM 192600), the most common monogenic cardiovascular disease, is an autosomal dominant disorder caused by mutations in approximately 20 genes encoding proteins of the cardiac sarcomere. Of those patients with positive genetic tests, approximately $70\\%$ are found to have mutations in the two most common genes, MYH7 and MYBPC3, whereas other genes, including those encoding troponin T, troponin I, Tropomyosin 1, and alpha-actin each account for a small proportion of patients ( $1\\%$ to $5\\,\\%$ ). \nPathogenesis \nOver 1500 mutations have been reported in genes encoding thick and thin myofilament proteins of the sarcomere or contiguous $Z$ disk. Mutations in several additional sarcomere (or calcium-handling) genes have been proposed, but with less evidence supporting pathogenicity. \nApproximately $60\\%$ of adult and pediatric patients with a family history of HCM will have a sarcomere mutation identified. In contrast, only approximately $30\\%$ of patients without a family history will have positive results, often due to sporadic or de novo mutations ( $65\\%$ of the probands) that may, however be passed on to the next generation. Approximately \n$3\\,\\%$ to $4\\%$ of males with HCM will have unrecognized Fabry disease, a lysosomal storage disorder caused by mutations in the $\\upalpha$ galactosidase A gene. \nPhenotype and Natural History \nHCM is characterized by left ventricular hypertrophy (LVH) (Fig.",
      "token_count": 481,
      "sentence_count": 16
    },
    {
      "id": "thompson_thompson_genetics_8th_edition_medicoscompanion_com_txt_752",
      "contents": " Expansion of $H D$ premutations to full mutations occurs through the male germline, whereas expansion of FMR1 (fragile $\\mathsf{X}$ syndrome) premutations to full mutations occurs through the female germline. Discuss possible mechanisms for sex biases in disease transmission.   \n4. By international consensus, asymptomatic at-risk children are not tested for $H D$ mutations because testing removes the child\u2019s choice to know or not know, testing results open the child to familial and social stigmatization, and testing results could affect educational and career decisions. When would it be appropriate to test asymptomatic at-risk children? What advances in medicine are necessary to make testing of all asymptomatic at-risk children acceptable? (Consider the reasoning underlying newborn screening.) \nManagement \nCurrently no curative treatments are available for HD. Therapy focuses on supportive care as well as pharmacological management of the behavioral and neurological problems. \nREFERENCES \nBordelon YM: Clinical neurogenetics: Huntington disease, Neurol Clin 31:1085\u2013 1094, 2013.   \nWarby SC, Graham RK, Hayden MR: Huntington disease. Available from: http:// www.ncbi.nlm.nih.gov/books/NBK1305/. \nINHERITANCE RISK \nEach child of a parent with HD has a $50\\%$ risk for inheriting a mutant $H D$ allele. Except for those alleles with incomplete \nHYPERTROPHIC CARDIOMYOPATHY (Cardiac Sarcomere Gene Mutations, MIM 192600) \nAutosomal Dominant \nPRINCIPLES \n\u2022 Locus heterogeneity \u2022 Age-related penetrance \u2022 Variable expressivity \nMAJOR PHENOTYPIC FEATURES \nAge at onset: Adolescence and early adulthood (age 12 to 21 years) Left ventricular hypertrophy \u2022 Myocardial crypts or scarring \u2022 Elongated mitral leaflets \u2022 Diastolic dysfunction \u2022 Heart failure \u2022 Sudden death \nHISTORY AND PHYSICAL FINDINGS \nA 30-year-old healthy man presents to clinic with dyspnea, palpitation, and chest pain. His father has congestive heart failure, and his brother had sudden cardiac death at 18 years of age while practicing football.",
      "token_count": 467,
      "sentence_count": 23
    },
    {
      "id": "friedreich_txt_9",
      "contents": " A longitudinal study identifed two groups; a \"low risk\" group (approximately $80\\%$ ) with normal ejection fraction that declined slowly and remained in the normal range and a \"high risk\" group (approximately $20\\%$ ) in whom ejection fraction declined into the abnormal range and was associated with high mortality [Pousset et al 2015]. Tose in the \"high risk\" group had longer GAA expansions on the shorter allele. Te degree of neurologic impairment did not predict whether an afected individual would have stable or rapid progression of cardiomyopathy. \nElectrocardiography (EKG) is abnormal in the vast majority, with T wave inversion, lef axis deviation, and repolarization abnormalities being most commonly seen [Dutka et al 1999]. \nSymptoms related to cardiomyopathy usually occur in the later stages of the disease [Dutka et al 1999] but in rare instances may precede ataxia [Alika\u015fifoglu et al 1999, Leonard & Forsyth 2001]. Quercia et al [2010] established the diagnosis of FRDA in a young child evaluated for sudden death. Subjective symptoms of exertional dyspnea $(40\\%)$ , palpitations $(11\\%)$ , and anginal pain may be present in moderately advanced disease. Arrhythmias (especially atrial fbrillation) and congestive heart failure frequently occur in the later stages of the disease and are the most common cause of mortality [Tsou et al 2011]. Coronary artery disease may occur and should be considered if there is angina and/or sudden deterioration in cardiac function [Giugliano & Sethi 2007]. \nUrinary issues. Bladder symptoms including urinary frequency and urgency were reported by $41\\%$ of individuals in one study [Delatycki et al 1999a]. A study of 158 individuals with FRDA revealed lower urinary tract symptoms in $82\\%$ with impact on quality of life in $22\\%$ of those [Musegante et al 2013]. Of 28 who underwent urodynamic studies, all had normal serum creatinine and four had upper urinary tract dilatation. \nSleep-disordered breathing.",
      "token_count": 479,
      "sentence_count": 14
    },
    {
      "id": "thompson_thompson_genetics_8th_edition_medicoscompanion_com_txt_726",
      "contents": "Thomas AS, Mehta A, Hughes DA: Gaucher disease: haematological presentations and complications, Br J Haematol 165:427\u2013440, 2014. \nX-Linked \nPRINCIPLES \n\u2022 Heterozygote advantage \u2022 Pharmacogenetics \nMAJOR PHENOTYPIC FEATURES \nAge at onset: Neonatal \u2022 Hemolytic anemia \u2022 Neonatal jaundice \nHISTORY AND PHYSICAL FINDINGS \nL.M., a previously healthy 5-year-old boy, presented to the emergency department febrile, pale, tachycardic, tachypneic, and minimally responsive; his physical examination was otherwise normal. The morning before presentation, he had been in good health, but during the afternoon, he had abdominal pain, headache, and fever; by late evening, he was tachypneic and incoherent. He had not ingested any medications or known toxins, and results of a urine toxicology screen were negative. Results of other laboratory tests showed massive nonimmune intravascular hemolysis and hemoglobinuria. After resuscitation, L.M. was admitted to the hospital; the hemolysis resolved without further intervention. L.M. was of Greek ethnicity; his parents were unaware of a family history of hemolysis, although his mother had some cousins in Europe with a \u201cblood problem.\u201d Further inquiry revealed that the morning before admission, L.M. had been eating fava beans from the garden while his mother was working in the yard. The physician explained to the parents that L.M. probably was deficient for glucose-6-phosphate dehydrogenase (G6PD) and that because of this, he had become ill after eating fava beans. Subsequent measurement of L.M.\u2019s erythrocyte G6PD activity confirmed that he had G6PD deficiency. The parents were counseled concerning L.M.\u2019s risk for acute hemolysis after exposure to certain drugs and toxins and given a list of compounds that L.M. should avoid. \nBACKGROUND \nDisease Etiology and Incidence \nG6PD deficiency (MIM 305900), a hereditary predisposition to hemolysis, is an X-linked disorder of antioxidant homeostasis that is caused by mutations in the G6PD gene.",
      "token_count": 482,
      "sentence_count": 23
    },
    {
      "id": "salih-myo_txt_1",
      "contents": "Agents/circumstances to avoid: Ibuprofen in those with congestive heart failure. \nGenetic counseling \nSalih myopathy is inherited in an autosomal recessive manner. Te parents of an afected child are obligate heterozygotes (i.e., carriers of one pathogenic variant) and are asymptomatic. At conception, each sib of an afected individual has a $25\\%$ chance of being afected, a $50\\%$ chance of being an asymptomatic carrier, and a $25\\%$ chance of being unafected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for a pregnancy at increased risk are possible if the pathogenic variants in the family have been identifed. \nDiagnosis \nSuggestive Findings \nSalih myopathy should be suspected in individuals with the following clinical, laboratory, electrophysiologic, imaging, and histopathology fndings. \nClinical \n\u2022 Muscle weakness manifesting during the neonatal period or in early infancy   \n\u2022 Delayed motor milestones but normal cognitive development   \n\u2022 Muscle weakness of limb-girdle distribution, myopathic face, variable degree of ptosis, and relative calf muscle hypertrophy   \n\u2022 Development of dilated cardiomyopathy between ages fve and 16 years   \n\u2022 Major heart rhythm disturbances leading to sudden death before age 20 years \nm creatine kinase (CK) is marginally to moderately increase \nElectrophysiologic \n\u2022 Electrocardiography. Lef axis deviation (lef anterior fascicular block) can be seen as early as age four years (Figure 1). With the onset of dilated cardiomyopathy, rhythm disturbances can include polymorphic premature ventricular complexes, bigeminism and trigeminism, couplets, triplets, atrioventricular heart block, atrioventricular nodal reentrant tachycardia, premature atrial complexes, premature ventricular complexes, and ventricular tachycardia.   \n\u2022 Electromyography shows myopathic features (low-amplitude polyphasic potentials of short duration).   \n\u2022 Nerve conduction studies are normal. \n",
      "token_count": 452,
      "sentence_count": 21
    },
    {
      "id": "rws_txt_1",
      "contents": " Tis idea is incorporated in the LQTS diagnostic scoring system proposed in the European Society of Cardiology guidelines for management of LQTS [Zeppenfeld et al 2022] (see Table 1). A LQTS risk score of $>\\!3.0$ in the absence of a secondary cause for QT prolongation is sufcient for a diagnosis of LQTS. \nCardiac Features \nT wave abnormalities include T wave alternans, notched T wave, broad-based and fattened T waves (see Adler et al [2020] and Wilde et al [2022] for concise examples and Tardo et al [2023] for a comprehensive review) and are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is \nusually self-terminating and may cause palpitations, dizziness, or syncope, the most common symptom in individuals with LQTS. Syncope is typically precipitous and without warning. A careful evaluation of medical history can help distinguish LQTS-associated syncope from common vasovagal and orthostatic forms of syncope in which presyncope and other warning symptoms occur. Absence of aura, incontinence, and postictal fndings help diferentiate LQTS-associated syncope from seizures. Te number of syncopal events in symptomatic individuals ranges from one to hundreds, averaging just a few. In some instances, TdP degenerates to ventricular fbrillation and aborted cardiac arrest (if the individual is defbrillated) or sudden death. \nCardiac events (i.e., syncope, cardiac arrest, or sudden cardiac death) may occur from infancy through middle age but are most common from the preteen years through the 20s, with the risk generally diminishing throughout that time period. Te usual age range of events difers somewhat for each genotype. Cardiac events are uncommon afer age 40 years; when present, they are ofen triggered by administration of a QT-prolonging drug or hypokalemia. Cardiac events in individuals over age 40 years are more likely associated with SCN5Arelated LQTS. \n",
      "token_count": 479,
      "sentence_count": 16
    },
    {
      "id": "brugada_txt_29",
      "contents": "Ikeda T, Takami M, Sugi K, Mizusawa Y, Sakurada H, Yoshino H. Noninvasive risk stratifcation of subjects with a Brugada-type electrocardiogram and no history of cardiac arrest. Ann Noninvasive Electrocardiol. 2005;10:396\u2013403. PubMed PMID: 16255748.   \nImaki R, Niwano S, Fukaya H, Sasaki S, Yuge M, Hirasawa S, Sato D, Sasaki T, Moriguchi M, Izumi T. Predictive impact of the inducibility of ventricular fbrillation in patients with Brugada-type ECG. Int Heart J. 2006;47:229\u201336. PubMed PMID: 16607050.   \nIto H, Yano K, Chen R, He Q, Curb JD. Te prevalence and prognosis of a Brugada-type electrocardiogram in a population of middle-aged Japanese-American men with follow-up of three decades. Am J Med Sci. 2006;331:25\u20139. PubMed PMID: 16415660.   \nKapplinger JD, Tester DJ, Alders M, Benito B, Berthet M, Brugada J, Brugada P, Fressart V, Guerchicof A, Harris-Kerr C, Kamakura S, Kyndt F, Koopmann TT, Miyamoto Y, Pfeifer R, Pollevick GD, Probst V, Zumhagen S, Vatta M, Towbin JA, Shimizu W, Schulze-Bahr E, Antzelevitch C, Salisbury BA, Guicheney P, Wilde AA, Brugada R, Schott JJ, Ackerman MJ. An international compendium of mutations in the SCN5Aencoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm. 2010;7:33\u201346. PubMed PMID: 20129283.   \nKaraca M, Dinckal MH. Monomorphic and propafenone-induced polymorphic ventricular tachycardia in Brugada syndrome: a case report. Acta Cardiol. 2006;61:481\u20134.",
      "token_count": 485,
      "sentence_count": 24
    },
    {
      "id": "cvt_txt_3",
      "contents": "\u2022 History of exercise- or emotion-related palpitations and dizziness in some individuals   \n\u2022 Sudden unexpected cardiac death triggered by acute emotional stress or exercise   \n\u2022 Family history of juvenile sudden cardiac death triggered by exercise or acute emotion   \n\u2022 Exercise-induced bidirectional or polymorphic ventricular arrhythmias \u26ac EKG during a graded exercise (exercise stress test) \\* allows ventricular arrhythmias to be reproducibly elicited in the majority of afected individuals. Typically, the onset of ventricular arrhythmias is 90-120 beats per minute. \u26ac With increase in workload, the complexity of arrhythmias progressively increases from isolated premature beats to bigeminy and runs of non-sustained ventricular tachycardia (VT). If the afecte d individual continues exercising, the duration of the runs of VT progressively increases and VT may become sustained. \u26ac An alternating $180^{\\circ}$ -QRS axis on a beat-to-beat basis, so-called bidirectional VT, is ofen the distinguishing presentation of CPVT arrhythmias [Priori et al 2021]. \u26ac Notably, some individuals with CPVT may also present with irregular polymorphic VT without a \"stable\" QRS vector alternans [Swan et al 1999, Priori et al 2002]. \u26ac Exercise-induced supraventricular arrhythmias (supraventricular tachycardia and atrial fbrillatio n) are common [Leenhardt et al 1995, Fisher et al 1999]. \n\u2022 Ventricular fbrillation occurring in the setting of acute stress \\* Note: Te resting EKG of individuals with CPVT is usually normal. Some authors have reported a lower-thannormal resting heart rate [Postma et al 2005] and others have observed a high incidence of prominent U waves, particularly in the precordial leads [Leenhardt et al 1995, Aizawa et al 2006]. Overall, these features are inconsistent and not sufciently specifc to allow diagnosis. Terefore, in many instances the origin of the syncope may be erroneously attributed to a neurologic disorder. Te exercise stress test is the single most important diagnostic test.",
      "token_count": 485,
      "sentence_count": 15
    },
    {
      "id": "hyper-pp_txt_2",
      "contents": "\u2022 History of at least two attacks of faccid limb weakness (which may also include weakness of the muscles of the eyes, throat, breathing muscles, and trunk)   \n\u2022 Onset or worsening of an attack as a result of oral potassium intake   \n\u2022 Disease manifestations before age 20 years   \n\u2022 Absence of cardiac arrhythmia between attacks   \n\u2022 Normal psychomotor development \nFamily history \n\u2022 Typically, at least one afected frst-degree relative \u2022 Note: Absence of a family history suggestive of hyperPP does not preclude the diagnosis. \nElectromyogram (EMG) \n\u2022 During the attack, EMG demonstrates a reduced number of motor units or may be silent (no insertional or voluntary activity).   \n\u2022 In the intervals between attacks, EMG may reveal myotonic activity (bursts of muscle fber action potentials with amplitude and frequency modulation, fring rate generally between 20 and $150\\,\\mathrm{Hz}$ ), even though myotonic stifness may not be clinically present.   \n\u2022 In some individuals, especially in those with permanent weakness, a myopathic pattern may be visible.   \n\u2022 Note: Approximately $50\\%$ of afected individuals have no detectable electric myotonia. \nSuggestive laboratory fndings during attacks \n\u2022 Hyperkalemia (serum potassium concentration $>5\\;\\mathrm{mmol/L}$ ) or an increase of serum potassium concentration of at least $1.5\\;\\mathrm{mmol/L}$ .   \n\u2022 Note: Serum potassium concentration seldom reaches cardiotoxic levels, but changes in the EKG (increased amplitude of T waves) may occur.   \n\u2022 Elevated serum creatine kinase (CK) concentration (sometimes 5-10x the normal range) \nSuggestive laboratory fndings between attacks \n\u2022 Normal serum potassium concentration and muscle strength between attacks Note: At the end of an attack of weakness, elimination of potassium via the kidney and reuptake of potassium by the muscle can cause transient hypokalemia that may lead to the misdiagnosis of hypokalemic periodic paralysis. \u2022 Elevated serum CK concentration with normal serum sodium concentration \nEstablishing the Diagnosis \n",
      "token_count": 448,
      "sentence_count": 21
    },
    {
      "id": "hyperchol_txt_0",
      "contents": "Familial Hypercholesterolemia \nSynonyms: Familial Hypercholesterol\u00e6mia, Hyperlipoproteinemia Type IIA   \nHannah E Ison, MS, LCGC,1 Shoa L Clarke, MD, PhD,2 and Joshua W Knowles, MD, PhD1   \nCreated: January 2, 2014; Updated: July 7, 2022. \nSummary \nClinical characteristics \nFamilial hypercholesterolemia (FH) is characterized by signifcantly elevated low-density lipoprotein cholesterol (LDL-C) that leads to atherosclerotic plaque deposition in the coronary arteries and proximal aorta at an early age and increases the risk of premature cardiovascular events such as angina and myocardial infarction; stroke occurs more rarely. Xanthomas (cholesterol deposits in tendons) may be visible in the Achilles tendons or tendons of the hands and worsen with age as a result of extremely high cholesterol levels. Xanthelasmas (yellowish, waxy deposits) can occur around the eyelids. Individuals with FH may develop corneal arcus (white, gray, or blue opaque ring in the corneal margin as a result of cholesterol deposition) at a younger age than those without FH. \nIndividuals with a more severe phenotype, ofen as a result of biallelic variants, can present with very signifcan t elevations in LDL-C $(>500\\mathrm{\\mg/dL})$ , early-onset coronary artery disease (CAD; presenting as early as childhood in some), and calcifc aortic valve disease. \nDiagnosis/testing \nA clinical diagnosis of FH can be established in a proband with characteristic clinical features and signifcantl y elevated LDL-C levels (typically ${>}190\\mathrm{\\;mg/dL}$ in adults and $>\\!160\\;\\mathrm{mg/dL}$ in children). Tree formal diagnostic criteria are used in Western countries. \n",
      "token_count": 434,
      "sentence_count": 14
    },
    {
      "id": "cadasil_txt_50",
      "contents": "Tikka S, Mykk\u00e4nen K, Ruchoux MM, Bergholm R, Junna M, Poyhonen M, Yki-Jarvinen H, Joutel A, Viitanen M, Baumann M, Kalimo H. Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. Brain. 2009;132:933\u20139. PubMed PMID: 19174371.   \nTuominen S, Juvonen V, Amberla K, Jolma T, Rinne JO, Tuisku S, Kurki T, Marttila R, Poyhonen M, Savontaus ML, Viitanen M, Kalimo H. Phenotype of a homozygous CADASIL patient in comparison to 9 age-matched heterozygous patients with the same R133C Notch3 mutation. Stroke. 2001;32:1767\u201374. PubMed PMID: 11486103.   \nTuominen S, Miao Q, Kurki T, Tuisku S, P\u00f6yh\u00f6nen M, Kalimo H, Viitanen M, Sipil\u00e4 HT, Bergman J, Rinne JO. Positron emission tomography examination of cerebral blood fow and glucose metabolism in young CADASIL patients. Stroke. 2004;35:1063\u20137. PubMed PMID: 15017012.   \nValenti R, Pescini F, Antonini S, Castellini G, Poggesi A, Bianchi S, Inzitari D, Pallanti S, Pantoni L. Major depression and bipolar disorders in CADASIL: a study using the DSM-IV semi-structured interview. Acta Neurol Scand. 2011;124:390\u20135. PubMed PMID: 21428968.   \nvan den Boom R, Lesnik Oberstein SA, Ferrari MD, Haan J, van Buchem MA. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR imaging fndings at diferen t ages--3rd-6th decades. Radiology. 2003;229:683\u201390. PubMed PMID: 14593195.   \n",
      "token_count": 476,
      "sentence_count": 21
    },
    {
      "id": "brugada_txt_1",
      "contents": "Brugada syndrome is characterized by cardiac conduction abnormalities (ST segment abnormalities in leads $\\mathrm{V}_{1}$ - $\\mathrm{V}_{3}$ on EKG and a high risk for ventricular arrhythmias) that can result in sudden death. Brugada syndrome presents primarily during adulthood, although age at diagnosis may range from infancy to late adulthood.  Te mean age of sudden death is approximately 40 years. Clinical presentations may also include sudden infant death syndrome (SIDS; death of a child during the frst year of life without an identifable cause) and sudden unexpected nocturnal death syndrome (SUNDS), a typical presentation in individuals from Southeast Asia. Other conduction defects can include frst-degree AV block, intraventricular conduction delay, right bundle branch block, and sick sinus syndrome. \nDiagnosis/testing \nTe diagnosis of Brugada syndrome is established clinically in an individual with characteristic EKG fndin gs and suggestive clinical history and/or family history. A molecular diagnosis can be established in an individual with characteristic features and identifcation of a heterozygous pathogenic variant in SCN5A or one of the additional 42 genes associated with Brugada syndrome. \nManagement \nTreatment of manifestations: Implantable cardioverter defbrillator (ICD) in individuals with a history of syncope or cardiac arrest; isoproterenol for electrical storms. During surgery and in the postsurgical recovery period persons with Brugada syndrome should be monitored by EKG. \nPrevention of primary manifestations: Quinidine ( $1{\\mathrm{-}}2\\ {\\mathrm{g}}$ daily). Treatment of asymptomatic individuals is controversial. \nSurveillance: EKG monitoring every one to two years for at-risk individuals with a family history of Brugada syndrome or who have a known pathogenic variant that can lead to Brugada syndrome. \n",
      "token_count": 414,
      "sentence_count": 13
    },
    {
      "id": "thompson_thompson_genetics_8th_edition_medicoscompanion_com_txt_848",
      "contents": " Children of heterozygous carriers have a $25\\%$ chance of being deficient, and all children of deficient individuals will be heterozygous carriers if the other parent is $\\ast1\\ast1$ homozygote. \nQUESTIONS FOR SMALL GROUP DISCUSSION \n1. VKORC1 polymorphisms account for significant variation in warfarin metabolism. Name several conditions in which warfarin therapy is commonly used.   \n2. The P450 enzymes encoded by the CYP genes are important to drug metabolism. Which CYP genes metabolize selective serotonin reuptake inhibitors? Does this result in toxicity or decreased effect?   \n3. Why do humans have genes for drug metabolism?   \n4. Suggest explanations for ethnic variation in these genes. \nREFERENCES \nRelling MV, Gardner EE, Sandborn WJ, et al: Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing, Clin Pharmacol Ther 89:387\u2013391, 2011. Scott SA: Personalizing medicine with clinical pharmacogenetics, Genet Med 13:987\u2013995, 2011. \nAutosomal Dominant \nPRINCIPLES \n\u2022 Gain-of-function mutation (factor V Leiden)   \n\u2022 Loss-of-function mutation (protein C mutations)   \n\u2022 Incomplete penetrance   \n\u2022 Genetic modifiers   \n\u2022 Environmental modifiers Heterozygote advantage   \n\u2022 Founder effect \nMAJOR PHENOTYPIC FEATURES \n\u2022 Age at onset: Adulthood \u2022 Deep venous thrombosis \nHISTORY AND PHYSICAL FINDINGS \nJ.J., a 45-year-old businessman of French and Swedish descent, suddenly developed shortness of breath on the day after a trans\u2013Pacific Ocean flight. His right leg was swollen and warm. Subsequent studies identified a thrombus in the popliteal and iliac veins and a pulmonary embolus. Both of his parents had had leg venous thromboses, and his sister had died of a pulmonary embolus during pregnancy. Based on his age and family history, J.J. was believed to have inherited a predisposition to thrombophilia. Screening for inherited causes of thrombophilia identified that J.J. was a carrier of factor V Leiden.",
      "token_count": 471,
      "sentence_count": 29
    },
    {
      "id": "A_Guide_To_Marfan_Syndrome_and_Related_Disorders_txt_29",
      "contents": " the back, neck or arms)   \nIs this kind of pain like anything you have ever felt   \nbefore? \niv. Express a Sense of Urgency \nEmphasize to the nurse or doctor that the patient: \nHas Marfan syndrome   \nIs at high risk for aortic dissection   \nIs concerned about the pain being from a dissection \nv. Carry an Emergency Alert Card \nWe have created an Emergency Alert Card for people to carry which identifies them as a person with Marfan syndrome or a related disorder and being at increased risk for aortic dissection. The card also identifies the proper tests the hospital should do to rule out aortic dissection. The card can be printed out from the patient toolkit on our website. \nvi. Wear a Medical Alert Bracelet \nMedical alert bracelets are helpful, especially if a person is unable to provide their medical history. The bracelet can relate a few key words or phrases that may be helpful to emergency department personnel. People with Marfan syndrome might want to include on their bracelet: Marfan syndrome, aortic aneurysm, risk for aortic dissection, heart valve and Coumadin $\\textsuperscript{\\textregistered}$ . Talk to your doctor to decide what is most important to include on your bracelet. \n\nvii. Contact Your Primary Care Doctor \nProvide emergency department staff with the patient\u2019s primary care physician\u2019s name and phone number. Ask them to call at once for any additional information that may be needed for appropriate treatment. \nviii. Be Familiar with Tests that Confirm or Rule Out a Diagnosis of Aortic Dissection \nThe diagnostic test used to confirm aortic dissection should be that test which the specific institution can perform in the most timely and accurate manner. This is usually a CT scan of the chest with IV contrast or a transesophageal echocardiogram. An MRI is occasionally used as a first test. If the patient has an allergy to IV dye, shellfish or Iodine, this should be mentioned to the emergency department personnel. It is important to remember that a chest x-ray may not show an aortic dissection and, if dissection is suspected, a normal chest x-ray should not deter further evaluation. \n",
      "token_count": 458,
      "sentence_count": 25
    },
    {
      "id": "26431_txt_214",
      "contents": "A variety of methodological factors can affect tilt response (Benditt et al., 1996; Moya et al., 2009; Sheldon, 2005), including the pretest sodium intake, the duration of the pretest fast, the ambient temperature in the laboratory, the time of day for the study, and whether the patient is permitted to remain on medications that have hemodynamic effects. Test factors can include the degree of patient movement permitted, whether there is invasive instrumentation (higher rates of syncope can be seen if arterial catheters are placed), the use of pharmacologic agents to provoke hypotension (e.g., isoproterenol [Natale et al., 1995], nitroglycerine), and the way an abnormal test is defined. Past studies often required reproduction of syncope as the end-point of testing. However, OH, POTS, and NMH can be identified before syncope occurs, and the table can be returned to the horizontal position. \nIn most laboratories, heart rate and blood pressure are monitored using beat-to-beat measurements, although in some centers only intermittent blood pressure measurements are made, for example, every 1\u20132 minutes for $5{-}10$ minutes, then every 5 minutes unless presyncopal symptoms are identified. Measurement of end-tidal $\\mathrm{CO}_{2}$ for detecting orthostatic hypocapnia is a helpful adjunctive technique (Naschitz et al., 2000; Natelson et al., 2007; Novak, 2018; Razumovsky et al., 2003; van Campen et al., 2020a). During both supine and upright phases, at approximately 5-minute intervals, patients are asked to rate changes in symptoms on a 0\u201310 scale (lightheadedness, fatigue, headache, mental fogginess, warmth, shortness of breath, nausea, and pain). \nHead-up tilt testing is not necessary in all individuals with orthostatic symptoms. Among those in whom the clinical history is consistent with reflex or neurally mediated syncope, and the heart is structurally normal, head-up tilt testing is no longer thought to be necessary for diagnosis (Benditt et al., 1996; Moya et al., 2009; Sheldon, 2005; Strickberger et al., \n2006).",
      "token_count": 494,
      "sentence_count": 18
    },
    {
      "id": "jln_txt_11",
      "contents": " For a complete, updated list see www.crediblemeds.org (registration required).   \n\u2022 Primary myocardial problems: cardiomyopathy, myocarditis, ischemia   \n\u2022 Central nervous or autonomic system injury; subarachnoid hemorrhage; stellate ganglion blockade \nHearing loss. Te diferential diagnosis for hearing loss includes consideration of other forms of syndromic and nonsyndromic disorders, as well as acquired disorders. For more information on hereditary hearing loss, see Genetic Hearing Loss Overview. \nOne disorder that should be noted specifcally is DFNB1, the most common autosomal recessive form of nonsyndromic hearing loss. DFNB1 is characterized by congenital, non-progressive, mild-to-profound sensorineural hearing impairment. No other associated medical fndings are present. Diagnosis of DFNB1 depends on molecular genetic testing to identify biallelic pathogenic variants in GJB2 (sequence variants as well as variants in upstream cis-regulatory elements that alter expression of the gap junction beta-2 protein [connexin 26]). JLNS should be suspected in any infant who has profound bilateral sensorineural hearing loss, no identifable GJB2 pathogenic variants, and a normal physical examination. \nBrugada syndrome is characterized by cardiac conduction abnormalities (ST-segment abnormalities in leads V1-V3 on EKG and a high risk for ventricular arrhythmias) that can result in sudden death. \nSudden infant death syndrome (SIDS) (OMIM 272120). Data from multicenter studies indicate that $9.5\\%$ of infants with SIDS may be heterozygous for functionally signifcant variants in one of the known LQTS-related genes. Sudden arrhythmic death may thus be an important contributor to SIDS; it is unknown what proportion of infants with SIDS have or would develop profound hearing impairment. Implementation of universal neonatal hearing screening, supplemented with early electrocardiography, may have the potential to identify high-risk children. However, a recent large population study did not fnd a higher incidence of JLNS in newborns identifed with hearing loss by universal screening [Chang et al 2014]. \nManagement \nEvaluations Following Initial Diagnosis \n",
      "token_count": 489,
      "sentence_count": 21
    },
    {
      "id": "hos_txt_10",
      "contents": "Genetic counseling is the process of providing individuals and families with information on the nature, mode(s) of inheritance, and implications of genetic disorders to help them make informed medical and personal decisions.  Te following section deals with genetic risk assessment and the use of family history and genetic testing to clarify genetic status for family members; it is not meant to address all personal, cultural, or ethical issues that may arise or to substitute for consultation with a genetics professional. \u2014ED. \nMode of Inheritance \nHolt-Oram syndrome (HOS) is inherited in an autosomal dominant manner. \nRisk to Family Members \nParents of a proband \n\u2022 Some individuals diagnosed with HOS have an afected parent.   \n\u2022 A proband with HOS ofen has the disorder as the result of a heterozygous de novo TBX5 pathogenic variant. Up to $85\\%$ of cases are caused by a de novo pathogenic variant [Elek et al 1991], while approximately $15\\%$ of cases are familial [Barisic et al 2014].   \n\u2022 Recommendations for the evaluation of parents of a proband with an apparent heterozygous de novo pathogenic variant include echocardiography, EKG, and hand x-rays (anterior/posterior view) to determine their afected status. Alternatively, molecular genetic testing can be performed on the parents if the TBX5 pathogenic variant in the proband has been identifed.   \n\u2022 If the pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, possible explanations include a de novo pathogenic variant in the proband or germline mosaicism in a parent. Presumed parental germline mosaicism has been reported [Braulke et al 1991].   \n\u2022 Te family history of some individuals diagnosed with HOS may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disorder in the afected parent. Terefore, an apparently negative family history cannot be confrmed unless appropriate clinical evaluation and/or molecular genetic testing has been performed on the parents of the proband.   \n\u2022 Note: If the parent is the individual in whom the pathogenic variant frst occurred, the parent may be mildly/minimally afected. \n\nSibs of a proband.",
      "token_count": 489,
      "sentence_count": 17
    },
    {
      "id": "lhon_txt_2",
      "contents": "Leber hereditary optic neuropathy (LHON) should be suspected in individuals with the following ophthalmologic, extraocular, neuroimaging, and biochemical fndings and family history. \nOphthalmologic \n\u2022 Bilateral, painless subacute visual failure that develops during young adult life \u26ac Visual acuity is severely reduced to 20/200 or worse in the majority of cases. \u26ac Visual feld testing by kinetic or static perimetry shows an enlarging dense central or centrocecal scotoma.   \n\u2022 Disk hyperemia, edema of the peripapillary retinal nerve fber layer, retinal telangiectasia, and increased vascular tortuosity Note: Approximately $20\\%$ of afected individuals show no fundal abnormalities in the acute stage.   \n\u2022 Optic disc atrophy Optic nerve dysfunction and absence of other retinal diseases on electrophysiologic studies (pattern electroretinogram and visual evoked potentials) \nExtraocular \nNeurologic abnormalities \u26ac Postural tremor \u26ac Peripheral neuropathy \u26ac Movement disorders \u26ac Multiple sclerosis-like illness \n\nNonspecifc myopathy Cardiac arrhythmias \nNeuroimaging. MRI is ofen normal, but may reveal white matter lesions and/or a high signal within the optic nerves [Matthews et al 2015]. \nBiochemical studies show respiratory chain defects that are more subtle than those seen in other mitochondrial genetic disorders. Te $\\mathrm{m.3460G{>}A}$ pathogenic variant in MT-ND1 is associated with the most severe biochemical phenotype (see Table 1). \nFamily history is consistent with maternal inheritance (e.g., afected females transmit the disorder to all ofspring; afected males do not transmit the disorder). Absence of a known family history does not preclude the diagnosis. \nEstablishing the Diagnosis \nTe diagnosis of LHON is established in a proband with the ocular manifestations listed in Suggestive Findings and/or by one of three common mtDNA pathogenic variants identifed by molecular genetic testing (see Table 2). \nNote: Identifcation of a mtDNA variant of uncertain signifcance does not by itself establish or rule out the diagnosis of this disorder. \n",
      "token_count": 479,
      "sentence_count": 19
    },
    {
      "id": "acpp_txt_16",
      "contents": " \u2022 Recommendations for the evaluation of parents of a proband with an apparent de novo pathogenic variant include: a detailed neurologic and cardiologic evaluation, 12-lead EKG, 24-hour Holter monitoring, and molecular genetic testing for the KCNJ2 pathogenic variant identifed in the proband. \n\u2022 Te family history of some individuals diagnosed with ATS may appear to be negative because of failure to recognize the disorder in family members, early death of the parent not attributed to the disease, or reduced penetrance. Terefore, an apparently negative family history cannot be confrmed unless appropriate neurologic and cardiologic evaluations and/or molecular genetic testing has been performed on the parents of the proband. \nSibs of a proband. Te risk to the sibs of the proband depends on the genetic status of the proband's parents: \n\u2022 If a parent of the proband is afected and/or has the $K C N J2$ pathogenic variant identifed in the proband, the risk to the sibs of inheriting the pathogenic variant is $50\\%$ .   \n\u2022 If the proband has a known ATS-related pathogenic variant that cannot be detected in the leukocyte DNA of either parent, the recurrence risk to sibs is slightly greater than that of the general population because of the possibility of parental germline mosaicism [Hasegawa et al 2015].   \n\u2022 If the parents have not been tested for the KCNJ2 pathogenic variant but are clinically unafected, the risk to the sibs of a proband appears to be low. However, sibs of a proband with clinically unafected parents are still presumed to be at increased risk for ATS because of the possibility of reduced penetrance in a heterozygous parent or the possibility of parental germline mosaicism [Hasegawa et al 2015]. \nOfspring of a proband. Each child of an individual with ATS has a $50\\%$ chance of inheriting the KCNJ2 pathogenic variant. \nOther family members.",
      "token_count": 450,
      "sentence_count": 12
    },
    {
      "id": "26431_txt_217",
      "contents": " We will monitor for any movements and will remind you not to move or wiggle. We want you to tell us if you are feeling anything different or uncomfortable during the test. Be as specifc as possible. We need to know if you feel you can\u2019t stay standing any longer, and if this is the case you can sit down. It is not necessary to remain standing for the entire 10 minutes, but we\u2019d like to measure how long you can do this. Each minute we will check your blood pressure and heart rate with an automatic measuring device.\u201d \nCOMMENTS: If the subject reports any changes in symptoms, list these in the comments column of the Standing Test Data Sheet (see below), corresponding to the time recorded for the BP and HR. Also note if and when the subject had to sit down before the completion of 10 minutes upright and mention whether the BP was performed sitting or while still standing. \nDEFINITIONS: \nPostural tachycardia syndrome (POTS): an increase in heart rate of at least 30 beats per minute (bpm) in adults or at least 40 bpm in adolescents (ages 12\u201319) from the lowest supine value to the maximum heart rate during the 10 minutes of standing, in the absence of orthostatic hypotension. POTS requires the presence of chronic orthostatic symptoms\u2014including lightheadedness, visual blurring or dimming, fatigue, exercise intolerance, headaches, cognitive diffculties (problems with concentration and memory, often termed \u201cbrain fog\u201d), shortness of breath, chest pain, and nausea\u2014and these are often reproduced during the standing test. \nThe increment in heart rate should be calculated from the lowest HR supine (either pre- or posttest, provided the patient has not had syncope or presyncope) and the peak HR standing. \nClassical orthostatic hypotension (cOH): a reduction in systolic BP of $\\geq20\\ \\mathsf{m m}$ or in diastolic $\\mathsf{B P}\\geq10\\ \\mathsf{m m}$ in the frst 3 minutes. \n",
      "token_count": 453,
      "sentence_count": 13
    },
    {
      "id": "cdsp_txt_6",
      "contents": " Older children with the infantile presentation may also develop myopathic manifestations including elevated CK, cardiomyopathy, and skeletal muscle weakness [Longo et al 2006, El-Hattab & Scaglia 2015]. \nAdulthood presentation. Several women have been diagnosed with CDSP afer newborn screening identife d low carnitine levels in their infants. About half of those women complained of fatigability, whereas the other half were asymptomatic. One woman was found to have dilated cardiomyopathy and another had arrhythmias [Schimmenti et al 2007, El-Hattab et al 2010, Lee et al 2010]. An asymptomatic adult male with CDSP has also been reported [Spiekerkoetter et al 2003]. \nPregnancy-related symptoms. Pregnancy is a metabolically challenging state because energy consumption signifcantly increases. In addition, during pregnancy plasma carnitine levels are physiologically lower than those of non-pregnant controls. Afected women can have decreased stamina or worsening of cardiac arrhythmia during pregnancy, suggesting that CDSP may manifest or exacerbate during pregnancy [Schimmenti et al 2007, El-Hattab et al 2010]. \nOther manifestations reported in individuals with CDSP in \n\u2022 Anemia [Cano et al 2008]   \n\u2022 Proximal muscle weakness and global developmental delays [Wang et al 2001] Respiratory distress [Erguven et al 2007] Arrhythmias and electrocardiographic abnormalities [Schimmenti et al 2007, Lee et al 2010], including long QT syndrome [De Biase et al 2012] \nHeterozygous carriers. Heterozygous carriers are asymptomatic [Amat di San Filippo et al 2008]. \nPrognosis. Infantile metabolic and childhood myopathic presentations of CDSP can be fatal if untreated (see Management). Te long-term prognosis is favorable as long as afected individuals remain on carnitine supplements. Repeated attacks of hypoglycemia or sudden death from arrhythmia have been described in afected individuals discontinuing carnitine supplementation [Longo et al 2006]. \nGenotype-Phenotype Correlations \n",
      "token_count": 482,
      "sentence_count": 19
    },
    {
      "id": "thompson_thompson_genetics_8th_edition_medicoscompanion_com_txt_830",
      "contents": "\u2022 Heterozygote advantage \u2022 Novel property mutation \u2022 Genetic compound Ethnic variation in allele frequencies \nMAJOR PHENOTYPIC FEATURES \nAge at onset: Childhood \u2022 Anemia \u2022 Infarction \u2022 Asplenia \nHISTORY AND PHYSICAL FINDINGS \nFor the second time in 6 months, a Caribbean couple brought their 24-month-old daughter, C.W., to the emergency department because she refused to bear weight on her feet. There was no history of fever, infection, or trauma, and her medical history was otherwise unremarkable; findings from the previous visit were normal except for a low hemoglobin level and a mildly enlarged spleen. Findings from the physical examination were normal except for a palpable spleen tip and swollen feet. Her feet were tender to palpation, and she would not stand up. Both parents had siblings who died in childhood of infection and others who may have had sickle cell disease. In view of this history and the recurrent painful swelling of her feet, her physician tested C.W. for sickle cell disease by hemoglobin electrophoresis. This test result documented sickle cell hemoglobin, Hb S, in C.W. \nBACKGROUND \nDisease Etiology and Incidence \nSickle cell disease (MIM 603903) is an autosomal recessive disorder of hemoglobin in which the $\\upbeta$ subunit genes have a missense mutation that substitutes valine for glutamic acid at amino acid 6. The disease is most commonly due to homozygosity for the sickle cell mutation, although compound heterozygosity for the sickle allele and a hemoglobin C or a $\\upbeta$ -thalassemia allele can also cause sickle cell disease (see Chapter 11). The prevalence of sickle cell disease varies widely among populations in proportion to past and present exposure to malaria (see Table). The sickle cell mutation appears to confer some resistance to malaria and thus a survival advantage to individuals heterozygous for the mutation. \nPathogenesis \nHemoglobin is composed of four subunits, two $\\upalpha$ subunits encoded by HBA on chromosome 16 and two $\\upbeta$ subunits encoded by the HBB gene on chromosome 11 (see Chapter 11).",
      "token_count": 480,
      "sentence_count": 20
    },
    {
      "id": "brugada_txt_14",
      "contents": "\u2022 EKG changes have low sensitivity in establishing the diagnosis [Corcia 2022]; \u2022 Identifcation of individuals at risk allows preventive measures such as fever control and avoidance of medications that can induce ventricular arrhythmias; Cardiac surveillance can be limited to family members who have the familial Brugada syndrome-related pathogenic variant [Benito et al 2009, Esc\u00e1rcega et al 2009, Nunn et al 2010]. \nIndividuals with a known pathogenic variant should undergo EKG monitoring every one to two years beginning at birth (see Surveillance). \nIf the pathogenic variant has not been identifed in the family, relatives should undergo EKG monitoring every one to two years beginning at birth (see Surveillance). If a type I EKG is identifed, further investigation is warranted. \nSee Genetic Counseling for issues related to testing of at-risk relatives for genetic counseling purposes. \nPregnancy Management \nHormonal changes during pregnancy can precipitate arrhythmic events in women with Brugada syndrome. Recurrent ventricular tachyarrhythmia can be inhibited, and the electrocardiographic pattern can normalize following IV infusion of low-dose isoproterenol followed by oral quinidine [Sharif-Kazemi et al 2011]. \nQuinidine is not known to be teratogenic to the developing fetus and is a preferred drug to treat arrhythmia in pregnancy. See MotherToBaby for more information about medication use during pregnancy. \nTherapies Under Investigation \nSearch ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: Tere may not be clinical trials for this disorder. \nGenetic Counseling \nGenetic counseling is the process of providing individuals and families with information on the nature, mode(s) of inheritance, and implications of genetic disorders to help them make informed medical and personal decisions.  Te following section deals with genetic risk assessment and the use of family history and genetic testing to clarify genetic status for family members; it is not meant to address all personal, cultural, or ethical issues that may arise or to substitute for consultation with a genetics professional. \u2014ED. \nMode of Inheritance \n",
      "token_count": 470,
      "sentence_count": 18
    }
  ],
  "scan_analyses": [
    {
      "scan_type": "ECG",
      "scan_date": "2025-03-25T09:09:28.833517",
      "file_name": "norm.png",
      "description": "ECG Scan for Patient",
      "analysis": "Okay, let's analyze this ECG tracing in detail. Here\u2019s a breakdown of what I observe, focusing on both normal findings and potential areas of concern:\n\n**Overall Impression:**\n\nThe ECG shows a sinus rhythm with a heart rate of approximately 75 beats per minute. The rhythm appears regular. However, there are some notable findings that warrant further investigation.\n\n**Detailed Analysis \u2013 Waveform by Waveform:**\n\n* **I, II, III Leads:** These leads show a normal P wave followed by a QRS complex. The QRS complexes are relatively narrow, suggesting a normal ventricular depolarization. The ST segments appear largely isoelectric (flat), which is a good sign.\n* **aVR, aVL Leads:**  Similar to the I, II, III leads, these show normal P waves and QRS complexes.  aVL shows a slight negative deflection during the QRS complex, which is expected.\n* **V1-V6 Leads:**  This is where we see the most significant findings:\n    * **T Wave Abnormalities:** The T waves in V3, V4, V5, and V6 are significantly *inverted* \u2013 they are negative in morphology. This is a key observation. Inverted T waves can be indicative of myocardial ischemia (lack of blood flow to the heart muscle) or infarction (past heart attack).\n    * **ST Segment Depression:** There is subtle ST-segment depression (flattening) in V3, V4, V5, and V6. This further supports the possibility of ischemia.\n    * **QRS Complexes:** The QRS complexes appear relatively narrow in V1-V6, but a slight widening is possible in V5 and V6, which could be related to the inverted T waves.\n* **Rhythm:** The rhythm is regular. The P waves are present and appear consistent. The PR interval appears to be within the normal range.\n\n**Measurements:**\n\n* **Rate:** Approximately 75 bpm (as estimated from the R-R intervals).\n* **Axis:** The QRS axis appears to be slightly rightward, which could be a normal variation or could be influenced by the inverted T waves.\n* **Intervals:** The PR interval appears normal. The QT interval is not easily measurable due to the ECG's resolution, but it seems within the expected range.\n\n**Possible Abnormalities and Considerations:**\n\n1. **Inverted T Waves:** The most prominent finding is the inverted"
    }
  ],
  "medical_entities": {
    "DETAILED_DESCRIPTION": [
      "02-16",
      "-R",
      "verted T"
    ],
    "SIGN_SYMPTOM": [
      "headache",
      "depolarization",
      "Abnormal",
      "T waves",
      "flow",
      "Depression",
      "ST-segment depression",
      "flattening",
      "widening"
    ],
    "HISTORY": [
      "illness"
    ],
    "DATE": [
      "03",
      "25"
    ],
    "DIAGNOSTIC_PROCEDURE": [
      "ECG",
      "rhythm",
      "heart rate",
      "form by",
      "form",
      "I, II, III Leads",
      "leads",
      "P wave",
      "QRS complex",
      "QRS complexes",
      "ventricular",
      "ST segments",
      "aVR, aVL Leads",
      "I, II, III leads",
      "P waves",
      "aVL",
      "V1-V6 Leads",
      "T Wave",
      "T waves",
      "ST Segment",
      "QRS Complexes",
      "Rhythm",
      "PR interval",
      "Rate",
      "Axis",
      "QRS axis",
      "Intervals",
      "QT interval",
      "Waves"
    ],
    "LAB_VALUE": [
      "sinus",
      "75 beats per minute",
      "regular",
      "normal",
      "narrow",
      "isoelectric",
      "flat",
      "slight negative deflection",
      "*inverted*",
      "negative",
      "within",
      "75 bpm",
      "slightly rightward"
    ],
    "BIOLOGICAL_STRUCTURE": [
      "V3",
      "V4",
      "V5",
      "V6",
      "myocardial",
      "heart muscle",
      "V1-V6",
      "V5 and V6"
    ],
    "DISEASE_DISORDER": [
      "ischemia",
      "infarction",
      "heart attack"
    ],
    "SEVERITY": [
      "subtle"
    ]
  },
  "analysis_date": "2025-03-25T14:24:18.867279",
  "created_at": "2025-03-25T14:24:18.867288"
}